Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPK1 | P28482 | 1/20 | 0.59 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.59 |
| ▸ | KMT2A | Q03164 | 6/20 | 0.53 |
| ▸ | NPC1 | O15118 | 2/20 | 0.53 |
| ▸ | POLB | P06746 | 1/20 | 0.50 |
| ▸ | ADRB2 | P07550 | 1/20 | 0.46 |
| ▸ | RAB9A | P51151 | 2/20 | 0.45 |
| ▸ | MEN1 | O00255 | 2/20 | 0.45 |
| ▸ | NTRK1 | P04629 | 1/20 | 0.44 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.42 |
| ▸ | HTT | P42858 | 1/20 | 0.42 |
| ▸ | CHRM3 | P20309 | 2/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14439499 | 0.91 | HSD17B10 (0.68) | MAPK1HSD17B10KMT2ANPC1POLB | |
| SCHEMBL13768423 | 0.88 | MAPK1 (0.56) | MAPK1HSD17B10KMT2ANPC1POLB | |
| SCHEMBL3966130 | 0.88 | MAPK1 (0.56) | MAPK1HSD17B10KMT2ANPC1POLB | |
| SCHEMBL3968485 | 0.86 | MAPK1 (0.62) | MAPK1HSD17B10KMT2ANPC1POLB | |
| SCHEMBL3968822 | 0.86 | MAPK1 (0.45) | MAPK1HSD17B10KMT2ANPC1POLB | |
| SCHEMBL13768521 | 0.85 | MAPK1 (0.53) | MAPK1HSD17B10KMT2ANPC1POLB | |
| SCHEMBL13768420 | 0.85 | MAPK1 (0.53) | MAPK1HSD17B10KMT2ANPC1POLB | |
| SCHEMBL13768683 | 0.84 | MAPK1 (0.56) | MAPK1HSD17B10KMT2ANPC1POLB | |
| SCHEMBL3967551 | 0.83 | MAPK1 (0.58) | MAPK1HSD17B10KMT2ANPC1POLB | |
| SCHEMBL14578353 | 0.83 | MAPK1 (0.53) | MAPK1HSD17B10KMT2ANPC1POLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7847108-B2 | such as N-[2-(4-bromophenyl)phenyl]-6-trifluoromethyl-2,3-dihydro-1,4-oxathiine-5-carboxamide, used for controlling unwanted microorganisms, for example, bacteria, fungi, yeasts, algae and slime organisms | BAYER CROPSCIENCE AG (DE) | 2010-12-07 | — | — | US | disclosed |
| EP-1599460-B1 | OXATHIIN CARBOXAMIDE | BAYER CROPSCIENCE AG (DE) | 2007-11-07 | — | — | EP | disclosed |
| US-20070004793-A1 | such as N-[2-(4-bromophenyl)phenyl]-6-trifluoromethyl-2,3-dihydro-1,4-oxathiine-5-carboxamide, used for controlling unwanted microorganisms, for example, bacteria, fungi, yeasts, algae and slime organisms | BAYER INTELLECTUAL PROPERTY GMBH (DE) | 2007-01-04 | — | — | US | disclosed |
| EP-1599460-A2 | OXATHIIN CARBOXAMIDE | Bayer CropScience Aktiengesellschaft (DE) | 2005-11-30 | — | — | EP | disclosed |
| WO-2004072023-A2 | OXATHIIN CARBOXAMIDE | BAYER CROPSCIENCE AKTIENGESELLSCHAFT (DE) | 2004-08-26 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070004793-A1 | such as N-[2-(4-bromophenyl)phenyl]-6-trifluoromethyl-2,3-dihydro-1,4-oxathiine-5-carboxamide, used for controlling unwanted microorganisms, for example, bacteria, fungi, yeasts, algae and slime organisms | Q6ZSR9, PFAS, NIT2 | MAPK1 3590/4885HSD17B10 3877/4885KMT2A 1138/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.